Cargando…
BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells
Germline mutations of the tumour suppressor gene BRCA1 are involved in the predisposition and development of breast cancer and account for 20–45% of all hereditary cases. There is an increasing evidence that these tumours are characterised by a specific phenotype and pattern of gene expression. We h...
Autores principales: | Tassone, P, Tagliaferri, P, Perricelli, A, Blotta, S, Quaresima, B, Martelli, M L, Goel, A, Barbieri, V, Costanzo, F, Boland, C R, Venuta, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747554/ https://www.ncbi.nlm.nih.gov/pubmed/12698198 http://dx.doi.org/10.1038/sj.bjc.6600859 |
Ejemplares similares
-
BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts
por: Lohse, I, et al.
Publicado: (2015) -
Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumour cell lines
por: Fustier, P, et al.
Publicado: (2003) -
Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro
por: Tassone, P, et al.
Publicado: (2003) -
Effects of oestrogens and anti-oestrogens on normal breast tissue from women bearing BRCA1 and BRCA2 mutations
por: Bramley, M, et al.
Publicado: (2006) -
BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells
por: Fan, S, et al.
Publicado: (2006)